[
  {
    "ts": "2025-12-23T05:16:10+00:00",
    "headline": "Jim Cramer Highlights Alphabet’s Diverse Portfolio",
    "summary": "Alphabet Inc. (NASDAQ:GOOGL) is one of the stocks Jim Cramer answered questions about. Starting the round of “Am I Diversified?”, a caller mentioned that their top five portfolio holdings are JPM, GOOGL, BA, PG, and AVGO. Cramer commented: “Let’s go to work in a year of practical investing, it’s upcoming…. Okay, so Broadcom, we know […]",
    "url": "https://finance.yahoo.com/news/jim-cramer-highlights-alphabet-diverse-051610017.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "ac731bad-0fd2-32bf-b761-c63d9463482d",
      "content": {
        "id": "ac731bad-0fd2-32bf-b761-c63d9463482d",
        "contentType": "STORY",
        "title": "Jim Cramer Highlights Alphabet’s Diverse Portfolio",
        "description": "",
        "summary": "Alphabet Inc. (NASDAQ:GOOGL) is one of the stocks Jim Cramer answered questions about. Starting the round of “Am I Diversified?”, a caller mentioned that their top five portfolio holdings are JPM, GOOGL, BA, PG, and AVGO. Cramer commented: “Let’s go to work in a year of practical investing, it’s upcoming…. Okay, so Broadcom, we know […]",
        "pubDate": "2025-12-23T05:16:10Z",
        "displayTime": "2025-12-23T05:16:10Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/af2bb6bdbc4f56cfaf197a2118a94cf1",
          "originalWidth": 1920,
          "originalHeight": 1440,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/nKnWLQdPRocSASPR1jBwNw--~B/aD0xNDQwO3c9MTkyMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/insidermonkey.com/af2bb6bdbc4f56cfaf197a2118a94cf1.cf.webp",
              "width": 1920,
              "height": 1440,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Ce5Jvbw3eVbn9NuhVM6ITg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/af2bb6bdbc4f56cfaf197a2118a94cf1.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/jim-cramer-highlights-alphabet-diverse-051610017.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/jim-cramer-highlights-alphabet-diverse-051610017.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GOOG"
            },
            {
              "symbol": "BA"
            },
            {
              "symbol": "JPM"
            },
            {
              "symbol": "AVGO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-23T05:05:56+00:00",
    "headline": "Why Analysts See St. James's Place Undervalued As Its Investment Story Evolves",
    "summary": "St. James's Place has seen its fair value estimate nudged higher to about £15.42 per share, as analysts grow more confident that the wealth manager can deliver on its earnings and capital generation plans. This modest uplift reflects a market narrative that is becoming more constructive, yet still mindful of regulatory and execution risks that could limit a more aggressive rerating. Stay tuned to see how investors can track these evolving price targets and the shifting story behind them over...",
    "url": "https://finance.yahoo.com/news/why-analysts-see-st-jamess-050556451.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "22cef689-6764-3f91-a5b6-17f65e4939d1",
      "content": {
        "id": "22cef689-6764-3f91-a5b6-17f65e4939d1",
        "contentType": "STORY",
        "title": "Why Analysts See St. James's Place Undervalued As Its Investment Story Evolves",
        "description": "",
        "summary": "St. James's Place has seen its fair value estimate nudged higher to about £15.42 per share, as analysts grow more confident that the wealth manager can deliver on its earnings and capital generation plans. This modest uplift reflects a market narrative that is becoming more constructive, yet still mindful of regulatory and execution risks that could limit a more aggressive rerating. Stay tuned to see how investors can track these evolving price targets and the shifting story behind them over...",
        "pubDate": "2025-12-23T05:05:56Z",
        "displayTime": "2025-12-23T05:05:56Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/4470f143ba4f4c0e99553a639759c619",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/P1sGmFSGN0yybgNh6O38Gw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4470f143ba4f4c0e99553a639759c619.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/FXkL4.r20Of_qLoEXUlCrQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/4470f143ba4f4c0e99553a639759c619.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/why-analysts-see-st-jamess-050556451.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/why-analysts-see-st-jamess-050556451.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "STJPF"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-23T11:01:00+00:00",
    "headline": "BeOne Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "SAN CARLOS, Calif., December 23, 2025--BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will participate in the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, with a presentation at 7:30 am PST.",
    "url": "https://finance.yahoo.com/news/beone-medicines-present-44th-annual-110100546.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "2ebcfc8f-e4b3-3fde-a245-ccabe6eb23b4",
      "content": {
        "id": "2ebcfc8f-e4b3-3fde-a245-ccabe6eb23b4",
        "contentType": "STORY",
        "title": "BeOne Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference",
        "description": "",
        "summary": "SAN CARLOS, Calif., December 23, 2025--BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will participate in the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, with a presentation at 7:30 am PST.",
        "pubDate": "2025-12-23T11:01:00Z",
        "displayTime": "2025-12-23T11:01:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/a7bf725260c948e5007a6e6536ab152c",
          "originalWidth": 28492,
          "originalHeight": 5743,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Na9obATFF63YaTT3.9fQYg--~B/aD01NzQzO3c9Mjg0OTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/a7bf725260c948e5007a6e6536ab152c.cf.webp",
              "width": 28492,
              "height": 5743,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/bqU5BUlPBOizua306Ohj8g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/a7bf725260c948e5007a6e6536ab152c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/beone-medicines-present-44th-annual-110100546.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/beone-medicines-present-44th-annual-110100546.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JPM"
            },
            {
              "symbol": "BEIGF"
            },
            {
              "symbol": "ONC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-23T12:30:00+00:00",
    "headline": "Bausch + Lomb to Participate in the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "VAUGHAN, Ontario, December 23, 2025--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that Chairman and CEO Brent Saunders, Executive Vice President and Chief Financial Officer Sam Eldessouky and Chief Medical Officer and Head of Research & Development Yehia Hashad, MD, will participate in a company presentation at the 44th Annual J.P. Morgan Healthcare Conference on Monday, Jan. 12, 2026, at 1:",
    "url": "https://finance.yahoo.com/news/bausch-lomb-participate-44th-annual-123000341.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "6cc798fd-db56-3ad8-8d32-d6c2420033b9",
      "content": {
        "id": "6cc798fd-db56-3ad8-8d32-d6c2420033b9",
        "contentType": "STORY",
        "title": "Bausch + Lomb to Participate in the 44th Annual J.P. Morgan Healthcare Conference",
        "description": "",
        "summary": "VAUGHAN, Ontario, December 23, 2025--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that Chairman and CEO Brent Saunders, Executive Vice President and Chief Financial Officer Sam Eldessouky and Chief Medical Officer and Head of Research & Development Yehia Hashad, MD, will participate in a company presentation at the 44th Annual J.P. Morgan Healthcare Conference on Monday, Jan. 12, 2026, at 1:",
        "pubDate": "2025-12-23T12:30:00Z",
        "displayTime": "2025-12-23T12:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/12a1da7b15dff69db7793b52ed3a9e04",
          "originalWidth": 4152,
          "originalHeight": 327,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/UtZqOqJPchXPh9ArgXy5QQ--~B/aD0zMjc7dz00MTUyO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/12a1da7b15dff69db7793b52ed3a9e04.cf.webp",
              "width": 4152,
              "height": 327,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/PQ71YCqUoHZUqqzjjfBb6w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/12a1da7b15dff69db7793b52ed3a9e04.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bausch-lomb-participate-44th-annual-123000341.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bausch-lomb-participate-44th-annual-123000341.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BLCO"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-23T12:00:00+00:00",
    "headline": "Bio-Techne to Present at the 2026 J.P. Morgan Healthcare Conference",
    "summary": "Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer, will present at the 2026 J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, at 9:00 a.m. PST. A live webcast of the presentation can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website at https://investors.bio-techne.com/ir-calendar.",
    "url": "https://finance.yahoo.com/news/bio-techne-present-2026-j-120000548.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "9869c13c-5ed7-3be1-9c3d-42e5c5c2f083",
      "content": {
        "id": "9869c13c-5ed7-3be1-9c3d-42e5c5c2f083",
        "contentType": "STORY",
        "title": "Bio-Techne to Present at the 2026 J.P. Morgan Healthcare Conference",
        "description": "",
        "summary": "Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer, will present at the 2026 J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, at 9:00 a.m. PST. A live webcast of the presentation can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website at https://investors.bio-techne.com/ir-calendar.",
        "pubDate": "2025-12-23T12:00:00Z",
        "displayTime": "2025-12-23T12:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/300dde1e8ea06c7a46071d80b01c0147",
          "originalWidth": 400,
          "originalHeight": 146,
          "caption": "BT Logo (PRNewsfoto/Bio-Techne Corporation)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ZyjXugroCeu5vlW6wYuCXA--~B/aD0xNDY7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/300dde1e8ea06c7a46071d80b01c0147.cf.webp",
              "width": 400,
              "height": 146,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/DPQWAvlZo522o8ucV.R5NA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/300dde1e8ea06c7a46071d80b01c0147.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bio-techne-present-2026-j-120000548.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bio-techne-present-2026-j-120000548.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "TECH"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-23T11:05:20+00:00",
    "headline": "How Auna’s Evolving Mexico Strategy Is Rewriting The Investment Story",
    "summary": "Auna's latest update has triggered a subtle reset in its long term fair value narrative, with the fair value estimate easing from about 10.67 to 10.42 as the discount rate edges higher from roughly 9.20% to 9.41% amid lingering concerns over regional expansion and leverage. While bulls frame this as a more achievable base that could set the stage for upside if Mexico ramps and the balance sheet improves, bears see the lower target as a reflection of tempered confidence in near term growth and...",
    "url": "https://finance.yahoo.com/news/auna-evolving-mexico-strategy-rewriting-110520745.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "f7b78b30-1566-3622-a216-23c7ccfffc3f",
      "content": {
        "id": "f7b78b30-1566-3622-a216-23c7ccfffc3f",
        "contentType": "STORY",
        "title": "How Auna’s Evolving Mexico Strategy Is Rewriting The Investment Story",
        "description": "",
        "summary": "Auna's latest update has triggered a subtle reset in its long term fair value narrative, with the fair value estimate easing from about 10.67 to 10.42 as the discount rate edges higher from roughly 9.20% to 9.41% amid lingering concerns over regional expansion and leverage. While bulls frame this as a more achievable base that could set the stage for upside if Mexico ramps and the balance sheet improves, bears see the lower target as a reflection of tempered confidence in near term growth and...",
        "pubDate": "2025-12-23T11:05:20Z",
        "displayTime": "2025-12-23T11:05:20Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/4a502612fd94fa7765656091ba791336",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/6RJ7wv.8gin.BsmtuC_3PA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4a502612fd94fa7765656091ba791336.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/vbHFagSfztJ8rwuj8OHCiw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/4a502612fd94fa7765656091ba791336.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/auna-evolving-mexico-strategy-rewriting-110520745.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/auna-evolving-mexico-strategy-rewriting-110520745.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AUNA"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-23T13:05:00+00:00",
    "headline": "BillionToOne to Participate in the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "MENLO PARK, Calif., Dec. 23, 2025 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced that Company management will participate in the 44th Annual J.P. Morgan Healthcare Conference. Management will present from 9:45am to 10:25am Pacific Time on Monday, January 12th, 2026. A live and archived webcast will be available on the “Events & Presentations” pa",
    "url": "https://finance.yahoo.com/news/billiontoone-participate-44th-annual-j-130500317.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "85e64635-b3ef-3b8c-a690-d1212552344a",
      "content": {
        "id": "85e64635-b3ef-3b8c-a690-d1212552344a",
        "contentType": "STORY",
        "title": "BillionToOne to Participate in the 44th Annual J.P. Morgan Healthcare Conference",
        "description": "",
        "summary": "MENLO PARK, Calif., Dec. 23, 2025 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced that Company management will participate in the 44th Annual J.P. Morgan Healthcare Conference. Management will present from 9:45am to 10:25am Pacific Time on Monday, January 12th, 2026. A live and archived webcast will be available on the “Events & Presentations” pa",
        "pubDate": "2025-12-23T13:05:00Z",
        "displayTime": "2025-12-23T13:05:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/4002b0a31048c4f4d512618615069dc4",
          "originalWidth": 809,
          "originalHeight": 425,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/siwkscFr8iz03dpboSO5GQ--~B/aD00MjU7dz04MDk7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/4002b0a31048c4f4d512618615069dc4.cf.webp",
              "width": 809,
              "height": 425,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/EwneB16hVRWWyPNzF1u0ig--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/4002b0a31048c4f4d512618615069dc4.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/billiontoone-participate-44th-annual-j-130500317.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/billiontoone-participate-44th-annual-j-130500317.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BLLN"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]